CS
ETNB

Candriam SCA’s 89bio ETNB Stock Holding History

Candriam SCA’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-766,211
Closed -$7.52M – 675
2025
Q2 		$7.52M Sell
766,211
-65,612
-8% -$543K 0.04% 294
2025
Q1 		$6.05M Sell
831,823
-223,838
-21% -$1.96M 0.04% 296
2024
Q4 		$8.26M Buy
1,055,661
+207,582
+24% +$1.71M 0.05% 287
2024
Q3 		$6.28M Hold
848,079
– – 0.04% 321
2024
Q2 		$6.79M Buy
848,079
+538,079
+174% +$4.8M 0.04% 297
2024
Q1 		$3.61M Buy
310,000
+30,000
+11% +$332K 0.02% 407
2023
Q4 		$3.13M Buy
280,000
+60,000
+27% +$551K 0.02% 409
2023
Q3 		$3.4M Hold
220,000
– – 0.02% 360
2023
Q2 		$4.17M Buy
220,000
+60,000
+38% +$1.05M 0.03% 364
2023
Q1 		$2.24M Buy
+160,000
New +$2.09M 0.02% 555
2022
Q1 		– Sell
-488,197
Closed -$6.38M – 819
2021
Q4 		$6.38M Hold
488,197
– – 0.04% 313
2021
Q3 		$9.56M Buy
488,197
+114,724
+31% +$2.1M 0.07% 280
2021
Q2 		$6.98M Buy
+373,473
New +$8.34M 0.05% 340

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Candriam SCA's ETNB Position: Q3 2025 in Review

Candriam SCA sold out of 89bio (ETNB) in Q3 2025, closing a stake of 766,211 shares — an estimated $7.52M sold.

Candriam SCA first reported a position in ETNB in Q2 2021 and held it in 13 quarters. The position peaked at $9.56M in Q3 2021. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Candriam SCA reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Candriam SCA sold 766,211 89bio shares in Q3 2025, an estimated $7.52M.
  • Candriam SCA first reported a position in 89bio in Q2 2021 and held it in 13 quarters.
  • Candriam SCA's 89bio position peaked at $9.56M in Q3 2021.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.